leflunomide has been researched along with Myositis, Multiple in 3 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Excerpt | Relevance | Reference |
---|---|---|
" We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide." | 7.75 | Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. ( Nagashima, M; Ochi, S; Taniguchi, K, 2009) |
"Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis." | 5.33 | Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006) |
" We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide." | 3.75 | Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. ( Nagashima, M; Ochi, S; Taniguchi, K, 2009) |
"Leflunomide is a new immunosuppressive drug recently introduced in the treatment of rheumatoid and psoriatic arthritis." | 1.33 | Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide. ( Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ochi, S | 1 |
Taniguchi, K | 1 |
Nagashima, M | 1 |
Luca, NJ | 1 |
Atkinson, A | 1 |
Hawkins, C | 1 |
Feldman, BM | 1 |
Lange, U | 1 |
Piegsa, M | 1 |
Müller-Ladner, U | 1 |
Strunk, J | 1 |
3 other studies available for leflunomide and Myositis, Multiple
Article | Year |
---|---|
Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Alanine Transaminase; Anti-Inflammatory Agents; Antirheumatic Agents; Arthri | 2009 |
Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Child; Drug Therapy, Combinati | 2012 |
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Topics: Antibodies, Antinuclear; Arthritis; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; | 2006 |